Medrx 1Q Loss Y238.00M Vs Loss Y429.00M

Dow JonesJun 10 16:56

Medrx Sees FY Loss Y1.50B

Dow JonesJun 10 16:56

SanBio, AeroEdge, and others

<290A> Recognized ¥2.178 billion in Syns subsidy income and ¥0.03 billion in insurance proceeds as non-operating income. <2937> Changed the shareholder benefit program of Sanxel. <369A> Introduced a shareholder benefit program at Etai. <4579> Received a one-time payment from Velovia Pharma, LLC (U.S.) related to the exercise of an option by RakuriA Sōyaku. <4586> Issued the 5th series of stock acquisition rights with an exercise price adjustment clause (potential shares: 14,782,000; proceeds: approximately ¥10.06 billion).

Fisco JapanMay 21 06:30

AViC, MicroAd, and others

GMonster establishes a subsidiary. Springsun Corporation, which handles comprehensive planning, development, construction, and operation of amusement parks, various entertainment venues, and parks, enters into a capital and business alliance through a third-party allotment of new shares (699,600 shares). The research and license agreement with Boehringer Ingelheim International GmbH for PRISM Bio has ended due to the expiration of the contract period. HMCom launches its next-generation AI implementation business.

Fisco JapanMay 18 06:30

Medrx: Quarterly Financial Results for the First Quarter of the Fiscal Year Ending December 2026 (Consolidated, Japanese GAAP)

JPXMay 15 14:30 · Announcements

Medrx: Regarding the consolidated earnings forecast for the fiscal year ending December 2026

JPXMay 15 14:30 · Announcements